Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: Subpopulation analysis of a prospective, open-label extension study of up to 48 weeks

Abstract Background: In a recent double-blind, placebo-controlled study, adjunctive levetiracetam (LEV) was reported to be effective and well tolerated during 5-day treatment in patients aged 1 month to

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2010-10, Vol.32 (11), p.1935-1950
Hauptverfasser:	Piña-Garza, Jesus Eric, MD, Schiemann-Delgado, Jimmy, MD, Yang, Haichen, MD, Duncan, Benjamin, MS, Hadac, Jan, MD, Hunter, Scott J., PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticonvulsants - administration & dosage Anticonvulsants - adverse effects Anticonvulsants - therapeutic use Biological and medical sciences Child, Preschool Children & youth Cognition & reasoning Convulsions & seizures Dose-Response Relationship, Drug Drug Therapy, Combination Drugs Epilepsies, Partial - drug therapy Epilepsy Female Follow-Up Studies Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Infant infants Internal Medicine levetiracetam long-term Male Medical Education Medical sciences Nervous system (semeiology, syndromes) Neurology Pediatrics Pharmacology. Drug treatments Piracetam - administration & dosage Piracetam - adverse effects Piracetam - analogs & derivatives Piracetam - therapeutic use Prospective Studies Quality of life Retrospective Studies Time Factors Treatment Outcome young children
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract Background: In a recent double-blind, placebo-controlled study, adjunctive levetiracetam (LEV) was reported to be effective and well tolerated during 5-day treatment in patients aged 1 month to
ISSN:	0149-2918 1879-114X
DOI:	10.1016/j.clinthera.2010.09.017